ABBVIE INC. vs. Amylyx Pharmaceuticals, Inc. Common Stock
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| ABBV | AMLX | |
|---|---|---|
| Market Cap | $521.41 billion | $3.79 billion |
ABBV leads on 1 of 1 size & scale factors.
Dividend
| ABBV | AMLX | |
|---|---|---|
| Dividend Yield | 2.47% | 5.69% |
AMLX leads on 1 of 1 dividend factors.
Risk & Sentiment
| ABBV | AMLX | |
|---|---|---|
| Short Interest | 0.85% | 0.00% |
AMLX leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, AMLX overview, AMLX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
